Trials / Completed
CompletedNCT06751017
A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants
A Phase 1 Study to Assess the Effect of Carbamazepine on the Pharmacokinetics of S-892216 in Healthy Adult Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Shionogi · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to investigate the effect of multiple-dose administration of carbamazepine on the pharmacokinetics of S-892216 in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-892216 | S-892216 will be administered orally as a tablet. |
| DRUG | Carbamazepine | Carbamazepine will be administered orally as a tablet. |
Timeline
- Start date
- 2024-12-17
- Primary completion
- 2025-02-24
- Completion
- 2025-02-24
- First posted
- 2024-12-27
- Last updated
- 2025-03-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06751017. Inclusion in this directory is not an endorsement.